Resistant KRAS(G12C) Inhibitor Subclones Exhibit Heterogeneous Alterations

Cancer Discov. 2022 Jan;12(1):13. doi: 10.1158/2159-8290.CD-RW2021-167. Epub 2021 Nov 19.

Abstract

KRAS(G12C) inhibitor (G12Ci) resistance exhibits a heterogeneous pattern with no one dominant alteration.